Application of MOSES Technology in BPH

Evaluation of Surgical and Functional Results of the Application of MOSES Technology in the Holmium Laser Prostate Enucleation as a Treatment for Tract Symptoms Lower Urinary Secondary to Benign Prostatic Hyperplasia

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04648176

Enrollment

400

Registered

2020-12-01

Start date

2020-03-06

Completion date

2023-06-30

Last updated

2020-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia (BPH), Lower Urinary Tract Symptoms

Keywords

laser, Holmium, HoLEP, Moses

Brief summary

In this study the investigators intend to compare the surgical and functional results of two different modalities of the use of the Holmium laser in prostate enucleation.

Detailed description

In this study the investigators intend to compare the surgical and functional results of two different modalities of the use of the Holmium laser in prostate enucleation using MOSES technology.

Interventions

DEVICEMoses technology

Using Holmium laser with Moses technology or conventional one

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

MALE

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Prostatic volume between 70-200cc * Acceptance to participate in the study.

Exclusion criteria

* Previous urethra stricture * Previous prostate surgery * Neurogenic bladder * Bladder tumor * Neurological disease with repercussion in the lower urinary tract. * Severe psychiatric illness * Inability of the patient to consent

Design outcomes

Primary

Measure	Time frame	Description
Hemoglobin	24 hours after the surgery	Hemoglobin change

Secondary

Measure	Time frame	Description
Hemostasis time	during the surgery	Hemostasis time change
Morcellating time	during the surgery	Morcellating time change
Surgery time	during the surgery	Surgery time change
Irrigated volume of serum	during the surgery	Irrigated volume of serum change
Enucleation time	during the surgery	Enucleation time change
urinary tract infection	one month after the surgery	urinary tract infection rate differences
lower urinary tract symptoms	through study completion, an average of 3 years	lower urinary tract symptoms rate differences
sexual function	through study completion, an average of 3 years	sexual function differences
complication rate	one month after the surgery	difference of complication rate

Countries

Spain

Contacts

Primary ContactAdrià Piñero Zomeño, MD

adria.pinero@gmail.com934893000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026